Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$113.24 - $131.95 $152,194 - $177,340
-1,344 Reduced 31.66%
2,901 $382,000
Q4 2023

Jan 24, 2024

SELL
$100.18 - $109.02 $141,454 - $153,936
-1,412 Reduced 24.96%
4,245 $462,000
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $582,388 - $646,764
5,657 New
5,657 $582,000
Q1 2023

May 03, 2023

SELL
$102.94 - $114.86 $94,910 - $105,900
-922 Reduced 16.89%
4,538 $482,000
Q4 2022

Feb 08, 2023

SELL
$87.44 - $112.11 $85,603 - $109,755
-979 Reduced 15.2%
5,460 $605,000
Q3 2022

Nov 07, 2022

SELL
$84.53 - $94.96 $63,651 - $71,504
-753 Reduced 10.47%
6,439 $564,000
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $600,460 - $680,650
7,192 New
7,192 $656,000
Q1 2022

May 09, 2022

SELL
$73.51 - $82.4 $409,524 - $459,050
-5,571 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$72.28 - $90.54 $505 - $633
-7 Reduced 0.13%
5,571 $428,000
Q3 2021

Oct 27, 2021

BUY
$71.68 - $78.83 $3,368 - $3,705
47 Added 0.85%
5,578 $454,000
Q2 2021

Jul 26, 2021

SELL
$70.31 - $77.77 $7,031 - $7,777
-100 Reduced 1.78%
5,531 $431,000
Q1 2021

May 07, 2021

BUY
$68.86 - $81.11 $146,878 - $173,007
2,133 Added 60.98%
5,631 $434,000
Q4 2020

Feb 03, 2021

SELL
$71.77 - $79.65 $70,549 - $78,295
-983 Reduced 21.94%
3,498 $283,000
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $102,525 - $116,212
1,401 Added 45.49%
4,481 $372,000
Q2 2020

Aug 11, 2020

BUY
$70.42 - $80.13 $216,893 - $246,800
3,080 New
3,080 $241,000
Q1 2019

May 03, 2019

SELL
$69.58 - $79.36 $60,186 - $68,646
-865 Closed
0 $0
Q4 2018

Jan 16, 2019

BUY
$65.24 - $75.71 $56,432 - $65,489
865 New
865 $66,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Advisors Preferred, LLC Portfolio

Follow Advisors Preferred, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Preferred, LLC with notifications on news.